Pharmacokinetic behavior of vincristine sulfate following administration of vincristine sulfate liposome injection Leanne EmbreeKaren GelmonLawrence D. Mayer ORIGINAL ARTICLE Pages: 347 - 352
Reduced activity of topoisomerase II in an Adriamycin-resistant human stomach-adenocarcinoma cell line Young Sook SonJae Myoung SuhMark T. Muller ORIGINAL ARTICLE Pages: 353 - 360
Induction of DNA damage, inhibition of DNA synthesis and suppression of c-myc expression by the anthracycline analog, idarubicin (4-demethoxy-daunorubicin) in the MCF-7 breast tumor cell line D. A. GewirtzJoyce K. RandolphFrank A. Fornari ORIGINAL ARTICLE Pages: 361 - 369
Investigation of the enterohepatic recirculation of Adriamycin and its metabolites by a linked-rat model Kamelia BehniaMehdi Boroujerdi ORIGINAL ARTICLE Pages: 370 - 376
A clinical pharmacokinetics study of carzelesin given by short-term intravenous infusion in a phase I study O. van TellingenC. J. A. PuntJ. H. Beijnen ORIGINAL ARTICLE Pages: 377 - 384
In vitro and in vivo interaction between cisplatin and topotecan in ovarian carcinoma systems Simona RomanelliPaola PeregoFranco Zunino ORIGINAL ARTICLE Pages: 385 - 390
Identification of the structural region of taxol that may be responsible for cytokine gene induction and cytotoxicity in human ovarian cancer cells Joanna M. WatsonDavid G. I. KingstonJ. Stephen Haskill ORIGINAL ARTICLE Pages: 391 - 397
The mechanism of polyamine analog-induced enhancement of cisplatin cytotoxicity in the U-251 MG human malignant glioma cell line Jonathan PaliwalGita JanumpalliHirak S. Basu ORIGINAL ARTICLE Pages: 398 - 402
Gemcitabine induces programmed cell death and activates protein kinase C in BG-1 human ovarian cancer cells Leanne CarteeGregory Louis Kucera ORIGINAL ARTICLE Pages: 403 - 412
Acute changes in urine protein excretion may predict chronic ifosfamide nephrotoxicity: a preliminary observation Fergus R. MacLeanRoderick SkinnerAndrew D. J. Pearson SHORT COMMUNICATION Pages: 413 - 416
Geldanamycin-induced cytotoxicity in human colon-cancer cell lines: evidence against the involvement of c-Src or DT-diaphorase Valerie G. BruntonGregor SteeleP. Workman SHORT COMMUNICATION Pages: 417 - 422
Effect of filgrastim on the pharmacokinetics of MX2 hydrochloride in patients with advanced malignant disease Denis J. MorganJohn S. HillMichael D. Green SHORT COMMUNICATION Pages: 423 - 426
Progression of Parkinson's disease with impairment of vision under carboplatin /cyclophosphamide therapy for ovarian cancer M. LinnE. BrodtMartin Kolben SHORT COMMUNICATION Pages: 427 - 428